Table 2.
Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)
| Days | Subjects at risk | Lost to follow up | Therapeutic failure | IR | CITF |
|---|---|---|---|---|---|
| 0 | 125 | 0 | 0 | 1.00 | 0 |
| 2 | 125 | 0 | 0 | 1.00 | 0 |
| 3 | 125 | 0 | 1 | 0.99 | 0.01 |
| 7 | 124 | 3 | 0 | 0.99 | 0.01 |
| 14 | 121 | 0 | 0 | 0.99 | 0.01 |
| 21 | 121 | 0 | 0 | 0.99 | 0.01 |
| 28 | 121 | 0 | 0 | 0.99 | 0.01 |
IR interval risk, CITF cumulative incidence of therapeutic failure.